PATENT CLAIM ANALYSIS

Application Number: 15875082
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure relates generally to a protocol to treat or prevent diseases or conditions associated with pathological forms of amyloid beta (Aβ), including Alzheimer's disease. Enabled herein is a reagent for use in the treatment and prophylaxis of Aβ-associated pathological conditions.

Claim (Index 48):
The method of  claim 45  or  46  or  47  for the detection of a disease selected from the list consisting of Alzheimer's disease, Down's syndrome, cognitive impairment or memory loss, Parkinson's disease, multi-infarct dementia, cerebral amyloid angiopathy, glaucoma, pre-eclampsia and a vascular disorder caused by pathogenic A\u03b2 peptide in blood vessels.

Metadata:
- Claim Count in Document: 164.0
- Percentile: 86.0
- Lexical Diversity: 1.17073
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14910172', '12724343', '12788116', '15397569', '11195207']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.802080282385505
- 35 USC 102 Novelty (BERT): 0.6127570177749638
- Combined Prediction Score: 0.783147955924451
- Mean Citation Score: 389.569902
- Max Citation Score: 613.6486
- Similarity Product: 491.1271162299871

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test